Co-Diagnostics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-3.0M | $998.7K |
| FY2017 | — | $3.9M | $3.5M |
| FY2018 | $1.9M | $-1.1M | $950.2K |
| FY2019 | — | $1.7M | $893.1K |
| FY2020 | — | $66.7M | $43.0M |
| FY2021 | — | $134.5M | $88.6M |
| FY2022 | — | $114.5M | $23.0M |
| FY2023 | — | $85.6M | $14.9M |
| FY2024 | — | $53.9M | $2.9M |
| FY2025 | — | $20.6M | $11.9M |